Agrylin and cardiac failure congestive Patient Reports February 11, 2012

Agrylin Side Effects Report #4869148-1
Agrylin side effect was reported by a Physician from UNITED STATES on Dec 28, 2005. Male patient, 80 years of age, weighting 124.0 lb, was diagnosed with myeloproliferative disorder, thrombocythaemia and was treated with Agrylin. After drug was administered, patient experienced the following side effects: cardiac failure congestive, ejection fraction decreased. Agrylin dosage: 2 MG AM AND 1 MG PM PO. During the same period patient was treated with HYDREA, TRAZODONE, PROTONIX, COMBIVENT, LASIX, LISINOPRIL, HYTRIN. Patient was hospitalized. Patient died on 11/29/2005.

Agrylin Side Effects Report #5085884-9
Agrylin side effect was reported by a Health Professional from UNITED STATES on Aug 10, 2006. Male patient, 74 years of age, weighting 162.0 lb, was diagnosed with myeloproliferative disorder and was treated with Agrylin. After drug was administered, patient experienced the following side effects: cardiac failure congestive, cardiac valve disease, international normalised ratio increased, platelet count decreased. Agrylin dosage: 0.5 MG TO 1 MG DAILY, UNK, ORAL - SEE IMAGE. During the same period patient was treated with COUMADIN, PROSCAR, COREG, LASIX. Patient was hospitalized. Patient recovered.

Agrylin Side Effects Report #4883128-1
Agrylin side effect was reported by a Physician from UNITED STATES on Jan 17, 2006. Male patient, 65 years of age, weighting 154.0 lb, was diagnosed with myeloproliferative disorder, thrombocythaemia and was treated with Agrylin. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac arrest , cardiac failure congestive, ventricular fibrillation. Agrylin dosage: 1 MG 3 TABS DAILY PO. Patient was hospitalized and became disabled. Patient recovered.

Agrylin Side Effects Report #4674731-2
Agrylin side effect was reported by a Consumer or non-health professional from on Apr 08, 2005. Female patient, 74 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Agrylin. After drug was administered, patient experienced the following side effects: anaemia, blood creatinine increased, blood urea increased, cardiac failure congestive, diabetic nephropathy, renal failure. Agrylin dosage: 0.5 MG, BID. During the same period patient was treated with ALLOPURINOL, HYDREA, GLEEVEC. Patient recovered.